ausamics

Sulfadiazine Powder

A sulfonamide antibiotic has inhibitory effect on bacterial cell wall synthesis by binding to the β-lactamase.

Cat. Number: AS-2020   |   CAS Number: 68-35-9

For ordering and getting more information about product details, please contact us.

Sulfadiazine Powder acts as a sulfonamide antibiotic, inhibiting bacterial folic acid synthesis by competitively blocking dihydropteroate synthetase. This enzyme is crucial for the production of tetrahydrofolic acid, an essential precursor for bacterial DNA and protein synthesis.

In microbiology, Sulfadiazine Powder is pivotal for formulating culture media, enabling selective inhibition of bacterial growth for isolating and identifying specific strains.

Sulfadiazine’s broad spectrum of activity encompasses various bacteria, including both Gram-positive and Gram-negative organisms. Clinically, Sulfadiazine powder treats infections caused by Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus.

In antimicrobial susceptibility testing, Sulfadiazine’s effectiveness is measured by determining the Minimum Inhibitory Concentration (MIC) of bacterial isolates.

Moreover, Sulfadiazine Powder is a valuable tool in researching antibiotic resistance mechanisms. By exposing bacteria to Sulfadiazine, scientists uncover pathways through which resistance develops, aiding in combating resistance.

Cat. NumberAS-2020
CAS Number68-35-9
MDL NumberMFCD00006065
Pubchem310280373
Molecular Weight250.28 g/mol
Molecular FormulaC10H10N4O2S
Storage Temperature20°C
Form and ColorPowder, white to yellow
Assay (on dry basis)99 – 101%
Loss on DryingMax. 0.5%
Sulfated ash≤ 0.1%
Heavy metals≤ 20 ppm

Document

 

Technical Data Sheet

Need Help? Chat with us!
Start a Conversation
Hi! Click to chat with AuSaMiCs on WhatsApp